The 1940s and 1950s were known as a ‘golden age’ of microbiology, with scientists making major advances in knowledge about bacteria as well as the development of many life-saving antibiotic drugs: penicillin, streptomycin, and tetracycline. After World War II, scientists also wanted to develop drug products that would supply beneficial bacteria to the gastrointestinal tract...
French family takes ownership as company begins its ascent to top global CDMO for live biotherapeutic products Biose Industrie manufactured several types of drugs throughout the 1970s and 1980s, having broad capabilities under the ownership of the Reti Group and then AzkoNobel. But it was under the leadership of its next owners that the company...
During its first two decades, Biose Industrie served a steady lineup of clients in bugs as drugs industry. The company leadership had the ambition to become the top global CDMO for live biotherapeutic products but knew the organisation would soon outgrow its existing facility located in an isolated area north of Aurillac, France. The company...
Aurillac, July 16, 2020 – Biose Industrie announced today the closing of a €30 million funding round led by Cathay Capital, alongside the company’s management team, banking partners and the Auvergne-Rhône-Alpes region. Thanks to this funding found, Biose Industrie will benefit from Cathay Capital’s support as it accelerates its development and strengthens its leadership position...
